Australia's most trusted
source of pharma news
Saturday, 18 October 2025
Posted 16 October 2025 AM
Novo Nordisk is pulling out of research into cell therapies, including a potential cure for type 1 diabetes, as part of the ongoing restructuring under new CEO Mike Doustdar.
Almost all 250 staff working in Novo’s cell therapy division would be laid off, said Danish newspaper Borsen, which broke the story.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.